{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T21:01:56Z","timestamp":1785186116457,"version":"3.55.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,6,7]],"date-time":"2020-06-07T00:00:00Z","timestamp":1591488000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,7]],"date-time":"2020-06-07T00:00:00Z","timestamp":1591488000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Natural Science for Youth Foundation","award":["81902055"],"award-info":[{"award-number":["81902055"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Virol"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s00705-020-04687-3","type":"journal-article","created":{"date-parts":[[2020,6,7]],"date-time":"2020-06-07T05:02:18Z","timestamp":1591506138000},"page":"1827-1835","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Targeting human cytomegalovirus IE genes by CRISPR\/Cas9 nuclease effectively inhibits viral replication and reactivation"],"prefix":"10.1007","volume":"165","author":[{"given":"Jun","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3122-0300","authenticated-orcid":false,"given":"Jiang","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuiying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,7]]},"reference":[{"issue":"11","key":"4687_CR1","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1086\/652438","volume":"50","author":"SL Bate","year":"2010","unstructured":"Bate SL, Dollard SC, Cannon MJ (2010) Cytomegalovirus seroprevalence in the United States: the national health and nutrition examination surveys, 1988\u20132004. Clin Infect Dis 50(11):1439\u20131447","journal-title":"Clin Infect Dis"},{"key":"4687_CR2","first-page":"125","volume":"154","author":"MS Chee","year":"1990","unstructured":"Chee MS, Bankier AT, Beck S et al (1990) Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. Curr Top Microbiol Immunol 154:125\u2013169","journal-title":"Curr Top Microbiol Immunol"},{"key":"4687_CR3","first-page":"297","volume":"325","author":"M Reeves","year":"2008","unstructured":"Reeves M, Sinclair J (2008) Aspects of human cytomegalovirus latency and reactivation. Curr Top Microbiol Immunol 325:297\u2013313","journal-title":"Curr Top Microbiol Immunol"},{"key":"4687_CR4","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.antiviral.2016.06.015","volume":"133","author":"J Deng","year":"2016","unstructured":"Deng J, Xiao J, Lv L, Ma P, Song X, Gao B, Gong F, Zhang Y, Xu J (2016) Immunosuppressive therapy alleviates murine cytomegalovirus recurrence by reducing TNF-\u03b1 post cell transplantation with lethal GVHD. Antiviral Res 133:130\u2013139","journal-title":"Antiviral Res"},{"issue":"3","key":"4687_CR5","doi-asserted-by":"publisher","first-page":"173","DOI":"10.7326\/0003-4819-118-3-199302010-00003","volume":"118","author":"JM Goodrich","year":"1993","unstructured":"Goodrich JM, Bowden RA, Fisher L, Keller C, Schoch G, Meyers JD (1993) Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant. Ann Intern Med 118(3):173\u2013178","journal-title":"Ann Intern Med"},{"issue":"4","key":"4687_CR6","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1182\/blood.V99.4.1159","volume":"99","author":"P Reusser","year":"2002","unstructured":"Reusser P, Einsele H, Lee J et al (2002) Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation. Blood 99(4):1159\u20131164","journal-title":"Blood"},{"issue":"3","key":"4687_CR7","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/S0041-1345(03)00316-6","volume":"35","author":"O Valdez","year":"2003","unstructured":"Valdez O, Gaspar A, Dickson J, Weigert A, Machado D (2003) Cytomegalovirus infection resistant to ganciclovir in a renal transplant patient. Transplant Proc 35(3):1081\u20131082","journal-title":"Transplant Proc"},{"issue":"4","key":"4687_CR8","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1034\/j.1399-3062.2002.t01-1-02008.x","volume":"4","author":"CM Isada","year":"2002","unstructured":"Isada CM, Yen-Lieberman B, Lurain NS et al (2002) Clinical characteristics of 13 solid organ transplant recipients with ganciclovir-resistant cytomegalovirus infection. Transpl Infect Dis 4(4):189\u2013194","journal-title":"Transpl Infect Dis"},{"issue":"3","key":"4687_CR9","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1111\/tid.12537","volume":"18","author":"PG Young","year":"2016","unstructured":"Young PG, Rubin J, Angarone M et al (2016) Ganciclovir-resistant cytomegalovirus infection in solid organ transplant recipients: a single-center retrospective cohort study. Transpl Infect Dis 18(3):390\u2013395","journal-title":"Transpl Infect Dis"},{"issue":"12","key":"4687_CR10","doi-asserted-by":"publisher","first-page":"e52827","DOI":"10.1371\/journal.pone.0052827","volume":"7","author":"LR Keyes","year":"2012","unstructured":"Keyes LR, Hargett D, Soland M et al (2012) HCMV protein LUNA is required for viral reactivation from latently infected primary CD14+ cells. PLoS One 7(12):e52827","journal-title":"PLoS One"},{"issue":"10","key":"4687_CR11","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1007\/s00705-011-1027-7","volume":"156","author":"MG Bego","year":"2011","unstructured":"Bego MG, Keyes LR, Maciejewski J, St JSC (2011) Human cytomegalovirus latency-associated protein LUNA is expressed during HCMV infections in vivo. Arch Virol 156(10):1847\u20131851","journal-title":"Arch Virol"},{"issue":"14","key":"4687_CR12","doi-asserted-by":"publisher","first-page":"7185","DOI":"10.1128\/JVI.02231-09","volume":"84","author":"M Reeves","year":"2010","unstructured":"Reeves M, Woodhall D, Compton T, Sinclair J (2010) Human cytomegalovirus IE72 protein interacts with the transcriptional repressor hDaxx to regulate LUNA gene expression during lytic infection. J Virol 84(14):7185\u20137194","journal-title":"J Virol"},{"issue":"Pt 3","key":"4687_CR13","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1099\/vir.0.015602-0","volume":"91","author":"MB Reeves","year":"2010","unstructured":"Reeves MB, Sinclair JH (2010) Analysis of latent viral gene expression in natural and experimental latency models of human cytomegalovirus and its correlation with histone modifications at a latent promoter. J Gen Virol 91(Pt 3):599\u2013604","journal-title":"J Gen Virol"},{"issue":"3\u20134","key":"4687_CR14","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.bbagrm.2009.08.001","volume":"1799","author":"J Sinclair","year":"2010","unstructured":"Sinclair J (2010) Chromatin structure regulates human cytomegalovirus gene expression during latency, reactivation and lytic infection. Biochim Biophys Acta 1799(3\u20134):286\u2013295","journal-title":"Biochim Biophys Acta"},{"issue":"1\u20133","key":"4687_CR15","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1007\/s12026-012-8304-8","volume":"54","author":"V Noriega","year":"2012","unstructured":"Noriega V, Redmann V, Gardner T, Tortorella D (2012) Diverse immune evasion strategies by human cytomegalovirus. Immunol Res 54(1\u20133):140\u2013151","journal-title":"Immunol Res"},{"issue":"5","key":"4687_CR16","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1111\/j.1462-5822.2012.01774.x","volume":"14","author":"F Goodrum","year":"2012","unstructured":"Goodrum F, Caviness K, Zagallo P (2012) Human cytomegalovirus persistence. Cell Microbiol 14(5):644\u2013655","journal-title":"Cell Microbiol"},{"issue":"1","key":"4687_CR17","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s12985-016-0634-z","volume":"13","author":"MC Arcangeletti","year":"2016","unstructured":"Arcangeletti MC, Vasile SR, Rodighiero I et al (2016) Human cytomegalovirus reactivation from latency: validation of a \u201cswitch\u201d model in vitro. Virol J 13(1):179","journal-title":"Virol J"},{"issue":"Suppl 3","key":"4687_CR18","first-page":"435","volume":"64","author":"Y Eizuru","year":"2006","unstructured":"Eizuru Y (2006) Latency and reactivation of HCMV. Nihon Rinsho 64(Suppl 3):435\u2013439","journal-title":"Nihon Rinsho"},{"key":"4687_CR19","first-page":"63","volume":"99","author":"K Kondo","year":"1995","unstructured":"Kondo K, Mocarski ES (1995) Cytomegalovirus latency and latency-specific transcription in hematopoietic progenitors. Scand J Infect Dis Suppl 99:63\u201367","journal-title":"Scand J Infect Dis Suppl"},{"issue":"20","key":"4687_CR20","doi-asserted-by":"publisher","first-page":"11137","DOI":"10.1073\/pnas.93.20.11137","volume":"93","author":"K Kondo","year":"1996","unstructured":"Kondo K, Xu J, Mocarski ES (1996) Human cytomegalovirus latent gene expression in granulocyte-macrophage progenitors in culture and in seropositive individuals. Proc Natl Acad Sci USA 93(20):11137\u201311142","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"4687_CR21","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.4049\/jimmunol.1502527","volume":"197","author":"B Pignoloni","year":"2016","unstructured":"Pignoloni B, Fionda C, Dell\u2019Oste V et al (2016) Distinct roles for human cytomegalovirus immediate early proteins IE1 and IE2 in the transcriptional regulation of MICA and PVR\/CD155 expression. J Immunol 197(10):4066\u20134078","journal-title":"J Immunol"},{"issue":"7","key":"4687_CR22","doi-asserted-by":"publisher","first-page":"e103308","DOI":"10.1371\/journal.pone.0103308","volume":"9","author":"ET Kim","year":"2014","unstructured":"Kim ET, Kim YE, Kim YJ, Lee MK, Hayward GS, Ahn JH (2014) Analysis of human cytomegalovirus-encoded SUMO targets and temporal regulation of SUMOylation of the immediate-early proteins IE1 and IE2 during infection. PLoS One 9(7):e103308","journal-title":"PLoS One"},{"issue":"4","key":"4687_CR23","doi-asserted-by":"publisher","first-page":"e02049-16","DOI":"10.1128\/JVI.02049-16","volume":"91","author":"EM Schilling","year":"2017","unstructured":"Schilling EM, Scherer M, Reuter N, Schweininger J, Muller YA, Stamminger T (2017) The human cytomegalovirus IE1 protein antagonizes PML nuclear body-mediated intrinsic immunity via the inhibition of PML De Novo SUMOylation. J Virol 91(4):e02049-16","journal-title":"J Virol"},{"issue":"23","key":"4687_CR24","doi-asserted-by":"publisher","first-page":"e01452-18","DOI":"10.1128\/JVI.01452-18","volume":"92","author":"W Hou","year":"2018","unstructured":"Hou W, Cruz-Cosme R, Wen F et al (2018) Expression of human cytomegalovirus IE1 leads to accumulation of mono-SUMOylated PML that is protected from degradation by herpes simplex virus 1 ICP0. J Virol 92(23):e01452-18","journal-title":"J Virol"},{"issue":"10","key":"4687_CR25","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1038\/nmeth.2649","volume":"10","author":"P Mali","year":"2013","unstructured":"Mali P, Esvelt KM, Church GM (2013) Cas9 as a versatile tool for engineering biology. Nat Methods 10(10):957\u2013963","journal-title":"Nat Methods"},{"issue":"5962","key":"4687_CR26","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1126\/science.1179555","volume":"327","author":"P Horvath","year":"2010","unstructured":"Horvath P, Barrangou R (2010) CRISPR\/Cas, the immune system of bacteria and archaea. Science 327(5962):167\u2013170","journal-title":"Science"},{"issue":"7385","key":"4687_CR27","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nature10886","volume":"482","author":"B Wiedenheft","year":"2012","unstructured":"Wiedenheft B, Sternberg SH, Doudna JA (2012) RNA-guided genetic silencing systems in bacteria and archaea. Nature 482(7385):331\u2013338","journal-title":"Nature"},{"issue":"6","key":"4687_CR28","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/j.cell.2014.05.010","volume":"157","author":"PD Hsu","year":"2014","unstructured":"Hsu PD, Lander ES, Zhang F (2014) Development and applications of CRISPR-Cas9 for genome engineering. Cell 157(6):1262\u20131278","journal-title":"Cell"},{"issue":"5","key":"4687_CR29","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3390\/v9050118","volume":"9","author":"J Deng","year":"2017","unstructured":"Deng J, Xiao J, Ma P, Gao B, Gong F, Lv L, Zhang Y, Xu J (2017) Manipulation of viral microRNAs as a potential antiviral strategy for the treatment of cytomegalovirus infection. Viruses 9(5):118","journal-title":"Viruses"},{"issue":"6166","key":"4687_CR30","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1126\/science.1247005","volume":"343","author":"O Shalem","year":"2014","unstructured":"Shalem O, Sanjana NE, Hartenian E et al (2014) Genome-scale CRISPR-Cas9 knockout screening in human cells. Science 343(6166):84\u201387","journal-title":"Science"},{"issue":"8","key":"4687_CR31","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/nmeth.3047","volume":"11","author":"NE Sanjana","year":"2014","unstructured":"Sanjana NE, Shalem O, Zhang F (2014) Improved vectors and genome-wide libraries for CRISPR screening. Nat Methods 11(8):783\u2013784","journal-title":"Nat Methods"},{"key":"4687_CR32","doi-asserted-by":"publisher","first-page":"2816","DOI":"10.3390\/v7062748","volume":"7","author":"J Xiao","year":"2015","unstructured":"Xiao J, Deng J, Lv L, Kang Q, Ma P, Yan F, Song X, Gao B, Zhang Y, Xu J (2015) Hydrogen peroxide induce human cytomegalovirus replication through the activation of p38-MAPK signaling pathway. Viruses 7:2816\u20132833","journal-title":"Viruses"},{"issue":"1","key":"4687_CR33","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.gene.2015.08.040","volume":"575","author":"MK Meshesha","year":"2016","unstructured":"Meshesha MK, Bentwich Z, Solomon SA, Avni YS (2016) In vivo expression of human cytomegalovirus (HCMV) microRNAs during latency. Gene. 575(1):101\u2013107","journal-title":"Gene."},{"issue":"1","key":"4687_CR34","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.gene.2016.09.014","volume":"594","author":"Q Zhang","year":"2016","unstructured":"Zhang Q, Lai MM, Lou YY, Guo BH, Wang HY, Zheng XQ (2016) Transcriptome altered by latent human cytomegalovirus infection on THP-1 cells using RNA-seq. Gene. 594(1):144\u2013150","journal-title":"Gene."},{"issue":"19","key":"4687_CR35","doi-asserted-by":"publisher","first-page":"8855","DOI":"10.1128\/JVI.00741-16","volume":"90","author":"KC Arend","year":"2016","unstructured":"Arend KC, Ziehr B, Vincent HA, Moorman NJ (2016) multiple transcripts encode full-length human cytomegalovirus IE1 and IE2 proteins during lytic infection. J Virol 90(19):8855\u20138865","journal-title":"J Virol"},{"issue":"1\u20132","key":"4687_CR36","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0378-1119(02)00566-8","volume":"290","author":"JP Castillo","year":"2002","unstructured":"Castillo JP, Kowalik TF (2002) Human cytomegalovirus immediate early proteins and cell growth control. Gene. 290(1\u20132):19\u201334","journal-title":"Gene."},{"key":"4687_CR37","first-page":"133","volume":"325","author":"MF Stinski","year":"2008","unstructured":"Stinski MF, Petrik DT (2008) Functional roles of the human cytomegalovirus essential IE86 protein. Curr Top Microbiol Immunol 325:133\u2013152","journal-title":"Curr Top Microbiol Immunol"},{"key":"4687_CR38","first-page":"7","volume":"26","author":"Advances in CMV management","year":"1998","unstructured":"Advances in CMV management (1998) Fomivirsen (Vitravene) approved. Proj Inf Perspect 26:7","journal-title":"Proj Inf Perspect"},{"issue":"4","key":"4687_CR39","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1128\/CMR.00009-10","volume":"23","author":"NS Lurain","year":"2010","unstructured":"Lurain NS, Chou S (2010) Antiviral drug resistance of human cytomegalovirus. Clin Microbiol Rev 23(4):689\u2013712","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"4687_CR40","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1002\/rmv.1873","volume":"26","author":"AB Campos","year":"2016","unstructured":"Campos AB, Ribeiro J, Boutolleau D, Sousa H (2016) Human cytomegalovirus antiviral drug resistance in hematopoietic stem cell transplantation: current state of the art. Rev Med Virol 26(3):161\u2013182","journal-title":"Rev Med Virol"},{"issue":"2","key":"4687_CR41","doi-asserted-by":"publisher","first-page":"e0192602","DOI":"10.1371\/journal.pone.0192602","volume":"13","author":"J Gergen","year":"2018","unstructured":"Gergen J, Coulon F, Creneguy A et al (2018) Multiplex CRISPR\/Cas9 system impairs HCMV replication by excising an essential viral gene. PLoS One 13(2):e0192602","journal-title":"PLoS One"},{"issue":"6","key":"4687_CR42","doi-asserted-by":"publisher","first-page":"e1005701","DOI":"10.1371\/journal.ppat.1005701","volume":"12","author":"FR van Diemen","year":"2016","unstructured":"van Diemen FR, Kruse EM, Hooykaas MJ et al (2016) CRISPR\/Cas9-Mediated Genome Editing of Herpesviruses Limits Productive and Latent Infections. PLoS Pathog 12(6):e1005701","journal-title":"PLoS Pathog"},{"key":"4687_CR43","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.gene.2006.07.021","volume":"384","author":"E Ioudinkova","year":"2006","unstructured":"Ioudinkova E, Arcangeletti MC, Rynditch A et al (2006) Control of human cytomegalovirus gene expression by differential histone modifications during lytic and latent infection of a monocytic cell line. Gene 384:120\u2013128","journal-title":"Gene"},{"issue":"2","key":"4687_CR44","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.virusres.2010.09.019","volume":"157","author":"MB Reeves","year":"2011","unstructured":"Reeves MB (2011) Chromatin-mediated regulation of cytomegalovirus gene expression. Virus Res 157(2):134\u2013143","journal-title":"Virus Res"}],"container-title":["Archives of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-020-04687-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00705-020-04687-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-020-04687-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,6]],"date-time":"2021-06-06T23:15:49Z","timestamp":1623021349000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00705-020-04687-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,7]]},"references-count":44,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["4687"],"URL":"https:\/\/doi.org\/10.1007\/s00705-020-04687-3","relation":{},"ISSN":["0304-8608","1432-8798"],"issn-type":[{"value":"0304-8608","type":"print"},{"value":"1432-8798","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,7]]},"assertion":[{"value":"31 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}